{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-1004.12",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 1004.12 - Requirements for dispensing facilities",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 1004.12 - Requirements for dispensing facilities\n\nState Regulations\n(a) Medical marihuana products shall not be\ndispensed or handled unless an individual with an active New York State\npharmacist license, as defined in article 137 of the Education Law, who has\ncompleted a four-hour course pursuant to section\n1004.1\nof this part, is on the\npremises and supervising the activity within the facility. (b) Dispensing facilities shall only sell\napproved medical marihuana products, related products necessary for the\napproved forms of administration of medical marihuana, and items that promote\nhealth and well-being subject to disapproval of the department and only in such\na manner as does not increase risks of diversion, theft or loss of approved\nmedical marihuana products or risk physical, chemical or microbial\ncontamination or deterioration of approved medical marihuana\nproducts. (c) No approved medical\nmarihuana products shall be vaporized or consumed on the premises of a\ndispensing facility. (d) Dispensing\nfacilities shall not dispense approved medical marihuana products to anyone\nother than a certified patient or designated caregiver. (e) When dispensing approved medical\nmarihuana products, the dispensing facility shall: (1)\nnot dispense an amount greater than a 30\nday supply to a certified patient, and not until the patient has exhausted all\nbut a seven day supply provided pursuant to any previously dispensed medical\nmarihuana product by any registered organization; (2)\nensure that medical marihuana product\npackaging shall not be opened by dispensing facility staff; (3)\nprovide a patient specific log of medical\nmarihuana products (brand, administration form, and dosage, and dates dispensed\nand any return of product) to the patient, the patient's designated caregiver, if applicable, or the patient's practitioner upon request; (4)\nensure the prescription monitoring\nprogram registry is consulted pursuant to 3343-a and section\n3364\nof the\n\nPublic Health Law, prior to any sales transactions and dispensing of any\napproved medical marihuana products by the facility. (f) The registered organization shall be\nresponsible for maintaining the confidentiality of patients and the integrity\nof the security of the facility at all times. Access to medical marihuana\nstorage areas and areas within the dispensing facility where security equipment\nand recordings are stored shall be restricted to: (1)\nregistered organization\nemployees; (2)\nemployees of the\ndepartment or its authorized representatives; (i) The dispensing facility shall maintain a\nvisitor log, which shall include the name of the visitor, date, time and\npurpose of the visit. The visitor log shall be available to the department at\nall times during operating hours and upon request. (ii)\n\nIf an unforeseen circumstance requires\nthe presence of a visitor and makes it impractical for the dispensing facility\nto obtain a waiver pursuant to this part, the dispensing facility shall record\nin the visitor log, the name of the visitor, date, time, purpose of the visit\nand the facts upon which the access was granted. (3)\nemergency personnel responding to an\nemergency, and; (4)\nother persons\nauthorized by a manager of the registered organization for the sole purpose of\nmaintaining the operations of the facility. (i) The dispensing facility shall maintain a visitor log of all\npersons, other than registered organization employees or emergency personnel\nresponding to an emergency, that access these secured areas, which shall\ninclude the name of the visitor, date, time and purpose of the visit. The\nvisitor log shall be available to the department at all times during operating\nhours and upon request. (g) The dispensing facility shall affix to\nthe approved medical marihuana product package a patient specific dispensing\nlabel approved by the department, that is easily readable, and firmly affixed\nand includes: (1)\nthe name and registry\nidentification number of the certified patient and designated caregiver, if\nany; (2)\nthe certifying\npractitioner's name; (3)\nthe\ndispensing facility name, address and phone number; (4)\nthe dosing and administration\ninstructions; (5)\nthe quantity and\ndate dispensed; (6)\nany\nrecommendation or limitation by the practitioner as to the use of medical\nmarihuana; and\n(7)\nthe expiration\ndate of the product once opened pursuant to section\n1004.11\n(m)(1)\nof\nthis Part. (h) The\ndispensing facility shall place the approved medical marihuana product in a\nplain outer package when dispensing to the patient or designated\ncaregiver. (i) The dispensing\nfacility shall ensure that each patient receives approved medical marihuana\nproduct from no more than two distinct lots for any 30-day supply\ndispensed. (j) The dispensing\nfacility shall include with each product package dispensed to a patient, a\ndepartment approved package safety insert. Information provided shall include\nbut not be limited to: (1)\nthe medical\nmarihuana product and brand; (2)\na\nlist of any excipients used; (3)\na\nwarning if there is any potential for allergens in the medical marihuana\nproduct; (4)\ncontraindications; (5)\nmore\nspecific dosage directions and instructions for administration; (6)\nwarning of adverse effects and/or any\npotential dangers stemming from the use of medical marihuana; (7)\ninstructions for reporting adverse\neffects as may be determined by the department; (8)\na warning about driving, operation of\nmechanical equipment, child care or making important decisions while under the\ninfluence of medical marihuana; (9)\ninformation on tolerance, dependence and withdrawal and substance abuse, how to\nrecognize what may be problematic usage of medical marihuana and obtain\nappropriate services or treatment; (10)\nadvice on how to keep the medical\nmarihuana product secure; (11)\nlanguage stating that the certified patient may not distribute any medical\nmarihuana product to anyone else; (12)\nlanguage stating that unwanted, excess, or contaminated medical marihuana product must be disposed of according to\nsection\n1004.20\nof this Part; and\n(13)\nlanguage stating that\n\"this product has not been analyzed by the FDA. There is limited information on\nthe side effects of using this product and there may be associated health\nrisks.\"\n(k) The\ndispensing facility shall store the medical marihuana product in a manner to\nensure that there is no contamination or deterioration of the medical marihuana\nproduct or its packaging. (l) If an\napproved medical marihuana product is returned to the dispensing facility, the\ndispensing facility shall: (1)\ndispose of\nsuch product pursuant to section\n1004.24\nof this part; (2)\nprovide the following information to the\ndepartment: (i) the name and registry\nidentification number of the certified patient for whom the product was\ndispensed; (ii)\nthe date of the\nreturn; (iii)\nthe brand and form\nbeing returned; (iv)\nthe quantity\nand/or weight being returned; (v) the reason for the return; (vi)\nthe\nname of the dispensing facility employee accepting the return; and\n(vii)\nany other information required by the\ndepartment; (3)\nensure\nthe returned marihuana product is securely stored, separate from working\ninventory while awaiting disposal. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n1004.12\n\nAdopted, New\n\nYork State Register April 15, 2015/Volume XXXVII, Issue 15, eff. 4/15/2015\n\nAmended\n\nNew\n\nYork State Register December 27, 2017 /Volume XXXIX, Issue 52, eff. 12/27/2017\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 41089
}